Table 3 Changes in the lung function parameters measured at clinic visits in comparison to baseline values
From: Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial
BDP/F 400/24 μg/day (N = 206) | p value | FP/S 500/100 μg/day (N = 216) | p value | |
|---|---|---|---|---|
FEV1, L | −0.06 (0.03) | 0.089 | −0.06 (0.03) | 0.109 |
FEV1% predicted | −1.72 (0.98) | 0.080 | −1.91 (0.98) | 0.051 |
PEF, L/min | −2.02 (4.57) | 0.658 | −4.28 (4.55) | 0.347 |
PEF % predicted | −0.90 (0.96) | 0.349 | −1.25 (0.95) | 0.190 |
Daytime symptoms score | −0.06 (0.07) | 0.327 | −0.03 (0.06) | 0.661 |
Night-time symptom score | 0.20 (0.11) | 0.067 | 0.07 (0.10) | 0.503 |